1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Nabil Adra: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma Pembrolizumab, Vorinostat - Renal Cell Carcinoma, Urinary Bladder Neoplasms | Phase 1 | Completed | Nabil Adra | 52 | 2016-02-23 | 2024-11-18 |
Carcinoma, Renal Cell (1) · Urinary Bladder Neoplasms (1)
Vorinostat (1) · pembrolizumab (1)
United States (1)
Roberto Pili, MD (1)